1. Home
  2. ALG vs BEAM Comparison

ALG vs BEAM Comparison

Compare ALG & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alamo Group Inc.

ALG

Alamo Group Inc.

HOLD

Current Price

$173.61

Market Cap

2.4B

Sector

Industrials

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$28.14

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALG
BEAM
Founded
1955
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.3B
IPO Year
1993
2020

Fundamental Metrics

Financial Performance
Metric
ALG
BEAM
Price
$173.61
$28.14
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
$225.00
$48.09
AVG Volume (30 Days)
128.5K
1.8M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
0.69%
N/A
EPS Growth
N/A
N/A
EPS
9.64
N/A
Revenue
$1,615,388,000.00
$55,701,000.00
Revenue This Year
$1.26
N/A
Revenue Next Year
$5.09
$26.52
P/E Ratio
$18.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$156.30
$13.53
52 Week High
$233.29
$35.25

Technical Indicators

Market Signals
Indicator
ALG
BEAM
Relative Strength Index (RSI) 54.81 60.74
Support Level $170.04 $26.17
Resistance Level $176.42 $28.64
Average True Range (ATR) 4.44 1.39
MACD 0.86 0.08
Stochastic Oscillator 59.23 78.14

Price Performance

Historical Comparison
ALG
BEAM

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: